Babies receive new vaccine to prevent RSV hospitalizations

nos.nl (Dutch)

Babies are now being vaccinated against the dangerous RSV virus, preventing thousands of hospitalizations annually. This immunization, called Nirsevimab, provides immediate protection for about six months. It contains antibodies, not requiring the baby to produce them, leading to minimal side effects. RSV causes severe respiratory infections in infants, being a leading cause of infant death globally. In the Netherlands, it leads to 1500-3000 hospitalizations yearly.


With a significance score of 5.5, this news ranks in the top 0.6% of today's 30387 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers: